Research.

Choueiri MB*, Shen JP*, Gross AM, Huang JK, Ideker T, Fanta P. ERCC1 and TS expression as prognostic and predictive biomarkers in metastatic colon cancer. PLoS One. 2015;10(6):e0126898.

SelectedPMID 26083491 — ERCC1 and TS expression as prognostic and predictive biomarkers in metastatic colon cancer, on PubMedDOI for ERCC1 and TS expression as prognostic and predictive biomarkers in metastatic colon cancer

Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nature Genetics. 2014;46(9):939–943.

SelectedPMID 25086664 — Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss, on PubMedDOI for Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss

Choueiri M, Jonasch E. Have molecularly targeted therapies improved overall survival in renal cell carcinoma? Current Oncology Reports. 2011;13(3):153–156.

SelectedPMID 21455732 — Have molecularly targeted therapies improved overall survival in renal cell carcinoma?, on PubMedDOI for Have molecularly targeted therapies improved overall survival in renal cell carcinoma?

Choueiri M, Tannir N, Jonasch E. Adjuvant and neoadjuvant therapy in renal cell carcinoma. Current Clinical Pharmacology. 2011;6(3):144–150.

PMID 21827393 — Adjuvant and neoadjuvant therapy in renal cell carcinoma, on PubMedDOI for Adjuvant and neoadjuvant therapy in renal cell carcinoma

Choueiri MB, Tu SM, Yu-Lee LY, Lin SH. The central role of osteoblasts in the metastasis of prostate cancer. Cancer and Metastasis Reviews. 2006;25(4):601–609.

SelectedPMID 17160554 — The central role of osteoblasts in the metastasis of prostate cancer, on PubMedDOI for The central role of osteoblasts in the metastasis of prostate cancer

Ye X, Choueiri M, Tu SM, Lin SH. Biology and clinical management of prostate cancer bone metastasis. Frontiers in Bioscience. 2007;12:3273–3286.

PMID 17485298 — Biology and clinical management of prostate cancer bone metastasis, on PubMedDOI for Biology and clinical management of prostate cancer bone metastasis

Lin SH, Lee YC, Choueiri MB, Wen S, Mathew P, Ye X, Do KA, Navone NM, Kim J, Tu SM, Yu-Lee LY, Logothetis CJ. Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clinical Cancer Research. 2008;14(12):3729–3736.

PMID 18559590 — Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer, on PubMedDOI for Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer

Ye X, Lee YC, Choueiri M, Chu K, Huang CF, Tsai WW, Kobayashi R, Logothetis CJ, Yu-Lee LY, Lin SH. Aberrant expression of katanin p60 in prostate cancer bone metastasis. The Prostate. 2012;72(3):291–300.

PMID 21681775 — Aberrant expression of katanin p60 in prostate cancer bone metastasis, on PubMedDOI for Aberrant expression of katanin p60 in prostate cancer bone metastasis

Choueiri MB, Otrock ZK, Tawil AN, El-Hajj II, El Saghir NS. Inflammatory breast cancer in a male. New Zealand Medical Journal. 2005;118(1218):U1566.

PMID 16027755 — Inflammatory breast cancer in a male, on PubMed

Choueiri MB, Makhoul NJ, Zreik TG, Mattar F, Adra AM, Eid R, Mroueh AM, Zalloua PA. The consanguinity effect on QF-PCR diagnosis of autosomal anomalies. Prenatal Diagnosis. 2006;26(5):409–414.

PMID 16532522 — The consanguinity effect on QF-PCR diagnosis of autosomal anomalies, on PubMedDOI for The consanguinity effect on QF-PCR diagnosis of autosomal anomalies

Makhoul NJ, Choueiri MB, Kattar MM, Soweid AM, Shamseddeen W, Estephan HC, Khalife J, Haddad A, Abi Rached A, Zalloua PA. Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon [research letter]. Journal of Clinical Virology. 2008;41(2):166–167.

PMID 18054277 — Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon [research letter], on PubMedDOI for Distribution of hepatitis C virus (HCV) genotypes among HCV infection risk groups in Lebanon [research letter]

Choueiri M, Mack P. The role of mTOR inhibitors and PI3K pathway blockade in RCC. In: Lara PN Jr, Jonasch E, eds. Kidney Cancer: Principles and Practice. Springer; 2012:209–223.

DOI for The role of mTOR inhibitors and PI3K pathway blockade in RCC

Jonasch E, Choueiri M. Mammalian target of rapamycin in renal cell carcinoma. In: Campbell SC, Rini BI, eds. Renal Cell Carcinoma: Clinical Management. Current Clinical Urology. Humana Press; 2013:317–337.

DOI for Mammalian target of rapamycin in renal cell carcinoma

Gross A, Choueiri M, Shen JP, et al. Association of methylation of genes in the taurine/hypotaurine pathway with worse prognosis in renal cell carcinoma. Journal of Clinical Oncology. 2013;31(15 suppl):e15562. ASCO Annual Meeting.

Gross AM, Orosco RK, Shen JP, et al. A prognostic model of head and neck cancer ties TP53 mutation to 3p loss. Cancer Research. 2014;74(19 suppl):3821. AACR Annual Meeting.